Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-08-05
1996-06-04
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514912, A61K 31535
Patent
active
055233015
ABSTRACT:
There is disclosed a method for maximizing the health of the optic nerve by application of topical .beta.-blockers to the eye. Maintaining or increasing retinal nerve fiber thickness has been found to have a link to the prevention of visual field loss and blindness.
REFERENCES:
patent: 3655663 (1972-04-01), Wasson
patent: 3657237 (1972-04-01), Weinstock et al.
patent: 3729469 (1973-04-01), Wasson
patent: 4195085 (1980-03-01), Stone
D. L. Epstein, et al., Ophthalmology 1989; 96; pp. 1460-1507.
B. Schwartz, Arch. Ophthalmol 1973; 89; pp. 272-277.
T. Takamoto, and B. Schwartz, Opthalmology 1989; 96: pp. 1315-1319.
A. Sommer, et al., Arch. ophtholmol 1984; 102: pp. 1766-1771.
Abstract of Journal of Curr. Eye Res. (1984), 3(10), 1199-202. Jay et al.
Medline Abstract of Chin Med J. 1993. 106(12) 922-7.
Amon Felix W.
Schwartz Bernard
Daniel Mark R.
Fay Zohreh
Korsen Elliott
Merck & Co. , Inc.
LandOfFree
Optic nerve health does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Optic nerve health, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Optic nerve health will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-383483